Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJtc Plc Regulatory News (JTC)

Share Price Information for Jtc Plc (JTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 891.00
Bid: 890.00
Ask: 892.00
Change: -1.00 (-0.11%)
Spread: 2.00 (0.225%)
Open: 892.00
High: 899.00
Low: 889.00
Prev. Close: 892.00
JTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Formation of Governance and Risk Committee

9 Dec 2022 14:52

RNS Number : 2677J
JTC PLC
09 December 2022
 

 

9 December 2022

 

JTC PLC

(the "Company" and together with its subsidiaries "JTC" or the "Group")

 

 

Formation of Governance and Risk Committee

 

In accordance with Listing Rule 9.6.11, JTC is pleased to announce a number of enhancements to the structure and composition of its Board Committees, including the formation of a stand-alone Governance and Risk Committee.

 

The newly-formed Governance and Risk Committee will be responsible for assisting the Board in its oversight of risk, including the ongoing monitoring, management and mitigation of principal and emerging risks, and advising the Board on the Group's overall risk appetite, tolerance and strategy. The Governance and Risk Committee, which will meet at least four times a year, comprises Kate Beauchamp, who has been appointed Chair of the Committee, Dermot Mathias, Michael Gray and Erika Schraner, all existing Independent Non-Executive Directors of the Company.

As a result of the formation of the new Governance and Risk Committee, the existing Audit & Risk Committee has been renamed the "Audit Committee" and the Terms of Reference, including the scope of responsibilities of the Audit Committee, amended appropriately.

These changes are intended to both enhance certain aspects of the Group's corporate governance arrangements and ensure the skillsets and experience of the Company's Non-Executive Directors are best utilised across its various Board Committees.

 

There have been no other changes to the information set out in LR 9.6.13R (2) to LR 9.6.13R (6). 

Board Committees

 

Following these changes the membership of the Board Committees will be as set out below:

 

· Audit Committee: Dermot Mathias (Chair), Michael Gray, Erika Schraner, Kate Beauchamp

· Governance and Risk Committee: Kate Beauchamp (Chair), Dermot Mathias, Michael Gray, Erika Schraner

· Nomination Committee: Erika Schraner (Chair), Mike Liston, Dermot Mathias, Michael Gray, Kate Beauchamp, Wendy Holley

· Remuneration Committee: Michael Gray (Chair), Mike Liston, Dermot Mathias, Erika Schraner, Kate Beauchamp

 

The new and revised terms of reference of the Committees will shortly be available to view and download from the Company's website: www.jtcgroup.com/investor-relations

 

 

For further information please contact:

 

Miranda Lansdowne

JTC (Jersey) Limited

Company Secretary

+44 1534 700 000

Miranda.Lansdowne@jtcgroup.com

 

About JTC

 

JTC is a publicly listed, global professional services business with deep expertise in fund, corporate and private client services. Every JTC person is an owner of the business and this fundamental part of our culture aligns us with the best interests of all our stakeholders. Our purpose is to maximize potential and our success is built on service excellence, long-term relationships and technology capabilities that drive efficiency and add value.

 

www.jtcgroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEALANESEAFFA
Date   Source Headline
30th Jun 20227:00 amRNSTotal Voting Rights
17th Jun 20224:41 pmRNSSecond Price Monitoring Extn
17th Jun 20224:35 pmRNSPrice Monitoring Extension
14th Jun 20227:00 amRNSIssue of Equity and Total Voting Rights
13th Jun 20224:00 pmRNSDirector's Share Dealing
13th Jun 20229:38 amRNSDirector's Share Dealing
1st Jun 20227:00 amRNSResult of AGM
5th May 202211:09 amRNSPDMR Shareholding
3rd May 20229:02 amRNSDirector's Other Appointments
28th Apr 20227:00 amRNSAnnual Financial Report and Notice of AGM
20th Apr 20227:00 amRNSVest and Grant of Conditional Share Awards
20th Apr 20227:00 amRNSDirector's Share Dealing
19th Apr 20227:00 amRNSFull Year Results
25th Mar 20227:00 amRNSAppointment of Independent Non-Executive Director
28th Feb 202210:00 amRNSPDMR Shareholding
22nd Feb 20228:59 amRNSDirector's Other Appointments
14th Feb 20229:00 amRNSDirector/PDMR Shareholding
11th Feb 20229:00 amRNSPDMR Shareholding
4th Feb 202212:00 pmRNSNotification of Director's Share Dealing
3rd Feb 20227:00 amRNSPre-close Full Year Trading Update
1st Feb 202210:00 amRNSPDMR Shareholding
1st Feb 20229:24 amRNSHolding(s) in Company
28th Jan 202212:51 pmRNSPDMR and PCA Shareholding Notification
31st Dec 20219:33 amRNSDirector's Other Appointments
31st Dec 20217:00 amRNSTotal Voting Rights
22nd Dec 20217:00 amRNSDirector's Other Appointments
21st Dec 20219:26 amRNSHolding(s) in Company
16th Dec 20217:00 amRNSAcquisition of Essential Fund Services, LLC
2nd Dec 20217:00 amRNSCompletion of Acquisition and Issue of Equity
23rd Nov 20213:58 pmRNSHolding(s) in Company
22nd Nov 20217:00 amRNSIssue of Equity
19th Nov 20217:00 amRNSAdmission of Shares
12th Nov 20212:56 pmRNSCompletion of Acquisition and Issue of Equity
26th Oct 20214:28 pmRNSHolding(s) in Company
11th Oct 20213:37 pmRNSHolding(s) in Company
8th Oct 20212:08 pmRNSHolding(s) in Company
7th Oct 20217:00 amRNSRESULTS OF PLACING
6th Oct 20215:02 pmRNSPROPOSED PLACING OF NEW ORDINARY SHARES
6th Oct 20214:59 pmRNSAcquisition of SALI
21st Sep 20217:01 amRNSInterim Results
21st Sep 20217:00 amRNSAcquisition of Ballybunion Capital Limited
17th Sep 20217:00 amRNSIssue of Equity
16th Sep 20217:00 amRNSAcquisition of Segue Partners
3rd Sep 20219:12 amRNSDirector's Other Appointments
23rd Aug 202110:00 amRNSDirector/PDMR Shareholding
19th Aug 20212:00 pmRNSNotification of Share Pledge by PDMR
11th Aug 20219:38 amRNSDirector's Other Appointments
28th Jul 202111:33 amRNSDirector Share Purchase
28th Jul 20219:33 amRNSDirector Share Purchase
22nd Jul 20217:00 amRNSGrant and Vesting of EIP Share Awards

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.